Literature DB >> 26950597

Therapeutic radiation and the potential risk of second malignancies.

Sophia C Kamran1, Amy Berrington de Gonzalez2, Andrea Ng3, Daphne Haas-Kogan3, Akila N Viswanathan3.   

Abstract

Radiation has long been associated with carcinogenesis. Nevertheless, it is an important part of multimodality therapy for many malignancies. It is critical to assess the risk of secondary malignant neoplasms (SMNs) after radiation treatment. The authors reviewed the literature with a focus on radiation and associated SMNs for primary hematologic, breast, gynecologic, and pediatric tumors. Radiation appeared to increase the risk of SMN in all of these; however, this risk was found to be associated with age, hormonal influences, chemotherapy use, environmental influences, genetic predisposition, infection, and immunosuppression. The risk also appears to be altered with modern radiotherapy techniques. Practitioners of all specialties who treat cancer survivors in follow-up should be aware of this potential risk. Cancer 2016;122:1809-21.
© 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  carcinogenesis; neoplasm; radiotherapy; risk; second primary; survivors

Mesh:

Year:  2016        PMID: 26950597     DOI: 10.1002/cncr.29841

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

Review 1.  DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives.

Authors:  Isabelle R Miousse; Laura E Ewing; Kristy R Kutanzi; Robert J Griffin; Igor Koturbash
Journal:  Crit Rev Oncog       Date:  2018

2.  Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.

Authors:  Tsz-Kwong Man; Geraldine Aubert; Melissa A Richard; Wanda LeJeune; Elmira Hariri; Tatiana Goltsova; Amos Gaikwad; Yan Chen; Jillian Whitton; Wendy M Leisenring; Michael A Arnold; Joseph P Neglia; Yutaka Yasui; Leslie L Robison; Gregory T Armstrong; Smita Bhatia; Maria M Gramatges
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-15       Impact factor: 4.090

3.  Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.

Authors:  Matthew Mossanen; Filipe L F Carvalho; Vinayak Muralidhar; Mark A Preston; Brendan Reardon; Jake R Conway; Catherine Curran; Dory Freeman; Sybil Sha; Guru Sonpavde; Michelle Hirsch; Adam S Kibel; Eliezer M Van Allen; Kent W Mouw
Journal:  Eur Urol       Date:  2021-12-23       Impact factor: 24.267

4.  Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.

Authors:  Kyung-Nam Koh; Keon Hee Yoo; Ho Joon Im; Ki Woong Sung; Hong Hoe Koo; Hyo Sun Kim; Jung Woo Han; Jong Hyung Yoon; Hyeon Jin Park; Byung-Kiu Park; Hee Jo Baek; Hoon Kook; Jun Ah Lee; Jae Min Lee; Kwang Chul Lee; Soon Ki Kim; Meerim Park; Young-Ho Lee; Chuhl Joo Lyu; Jong Jin Seo
Journal:  J Korean Med Sci       Date:  2016-05-18       Impact factor: 2.153

5.  Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation.

Authors:  Candice A M Sauder; Qian Li; Alisha Othieno; Daisy Cruz; Mili Arora; Richard J Bold; Fredrick J Meyers; Theresa H M Keegan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09       Impact factor: 4.090

6.  Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.

Authors:  Julian C Assmann; Don E Farthing; Keita Saito; Natella Maglakelidze; Brittany Oliver; Kathrynne A Warrick; Carole Sourbier; Christopher J Ricketts; Thomas J Meyer; Steven Z Pavletic; W Marston Linehan; Murali C Krishna; Ronald E Gress; Nataliya P Buxbaum
Journal:  Blood       Date:  2021-01-07       Impact factor: 25.476

Review 7.  Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.

Authors:  Mohammad Habash; Luis C Bohorquez; Elizabeth Kyriakou; Tomas Kron; Olga A Martin; Benjamin J Blyth
Journal:  Cancers (Basel)       Date:  2017-10-27       Impact factor: 6.639

8.  Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial.

Authors:  Isabel Heidegger; Renate Pichler; Axel Heidenreich; Wolfgang Horninger; Andreas Pircher
Journal:  Transl Androl Urol       Date:  2018-03

Review 9.  Orbital pathology - Iatrogenic findings and artefacts.

Authors:  Caroline Thaung
Journal:  Saudi J Ophthalmol       Date:  2018-02-21

10.  TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency.

Authors:  Kristine Lillebø Holm; Randi Gussgard Syljuåsen; Grete Hasvold; Lene Alsøe; Hilde Nilsen; Kristina Ivanauskiene; Philippe Collas; Sergey Shaposhnikov; Andrew Collins; Randi Larsen Indrevær; Pål Aukrust; Børre Fevang; Heidi Kiil Blomhoff
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.